Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cigna Corp (NY:CI)

296.86 +6.51 (+2.24%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Looking At Cigna Group's Recent Unusual Options Activity
 
Via Benzinga
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Cigna Group Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
 
Via Benzinga
Why I Bought the Dip in UnitedHealth Group
This top health insurer scans as a downright bargain at current levels. 
Via The Motley Fool
UnitedHealth Stock Gets Fresh Fuel From Dividend Nod — Now Retail Traders Are Whispering About Warren Buffett Taking Stake
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares. 
Via Stocktwits
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened
Via Stocktwits
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
Earnings Scheduled For July 31, 2025
 
Via Benzinga
CI Q2 Deep Dive: Product Innovation and Margins Tested Amid Industry Pressures
Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per... 
Via StockStory
5 Insightful Analyst Questions From Cigna’s Q2 Earnings Call
Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite revenue and adjusted earnings per share both coming in ahead of Wall Street... 
Via StockStory
Topics Earnings
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Cigna (CI) Q2 Revenue Jumps 11%
Via The Motley Fool
Topics Artificial Intelligence
What 11 Analyst Ratings Have To Say About Cigna Group
 
Via Benzinga
5 Dividend Stocks With Solid Returns And More Growth Ahead
 
Via Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation. 
Via Benzinga
Trump Reportedly Taps Wall Street Banks To Explore Fannie, Freddie Public Offering Strategy — Retail Eyes Fresh Highs
According to a Bloomberg News report, Trump already met JPMorgan Chase & Co. CEO Jamie Dimon last week at the White House, followed by talks with Goldman Sachs CEO David Solomon on Thursday. 
Via Stocktwits
Topics Government
Cigna Sees Elevated Cost Trends To Continue Into Next Year
Via Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Gapping S&P500 stocks in Thursday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
The Cigna Group (NYSE:CI) Reports Q2 Revenue Beat and Reaffirms Full-Year Outlook Despite Slight EPS Miss
Cigna Group (NYSE:CI) beat Q2 revenue estimates but slightly missed on EPS, reaffirming full-year guidance. Shares rose 4.4% pre-market as investors focused on growth. 
Via Chartmill
Cigna (NYSE:CI) Reports Strong Q2
Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per share... 
Via StockStory
Topics Artificial Intelligence
Cigna (CI) Q2 Earnings Report Preview: What To Look For
Health insurance company Cigna (NYSE:CI) will be reporting earnings this Thursday before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Benzinga Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare — And Trade Deal Optimism Boosts Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Centene, Cigna, Others Drop As Molina's Results Rattle Sector
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene. 
Via Benzinga
2 Profitable Stocks Worth Your Attention and 1 That Underwhelm
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Cigna Group Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
3 Value Stocks for Long-Term Investors
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Why Cigna (CI) Shares Are Sliding Today
Shares of health insurance company Cigna (NYSE:CI) fell 3.1% in the afternoon session after the major indices pulled back (Nasdaq -0.8%, S&P 500 -0.77%), largely due to escalating concerns surrounding... 
Via StockStory
Topics Artificial Intelligence Government Stocks
UnitedHealth, Centene Hit Hard By Guidance Shock, Trump's Medicaid Push
UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation. 
Via Benzinga
Topics Government
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.